Other

Sacklers agree to new $6bn Purdue US settlement over opioids

The Sackler family will pay up to $6 billion to address damage linked to the US opioid crisis under an amended Purdue Pharma bankruptcy plan following an agreement with holdout states, according to a court filing Thursday.

Medical research

Waterless artificial kidney may be the treatment of the future

Every year, more people die of kidney disease than breast cancer. The Centers for Disease Control and Prevention estimates that 37 million people in the United States—15% of U.S. adults—have some form of chronic kidney ...

Medical research

Brain's stem cells 'eavesdrop' to find out when to act

Working with mice, Johns Hopkins researchers say they have figured out how stem cells found in a part of the brain responsible for learning, memory and mood regulation decide to remain dormant or create new brain cells. Apparently, ...

Other

Purdue Pharma owners up opioid settlement offer to $6 bn

The owners of Purdue Pharma, maker of OxyContin, have offered to pay up to $6 billion to victims of the US opioid crisis to settle an avalanche of litigation, according to a report filed Friday by a federal mediator.

Neuroscience

Oligodendroglia cells protect neurons against neurodegeneration

(Medical Xpress) -- Johns Hopkins researchers say they have discovered that the central nervous system's oligodendroglia cells, long believed to simply insulate nerves as they "fire" signals, are unexpectedly also vital to ...

page 2 from 14